Founded in 1908, LEO Pharma is a foundation-owned company that has devoted decades of research and development to advance the science of thrombosis, setting new standards of care, always putting the patient first. It is currently headquartered in Denmark with a global team of 5,700 people, serving 80 million patients in 130 countries.
Its mission is to advance the care of patients with thrombosis – this advance is driven by knowledge, collaboration and curiosity, while looking beyond today in order to constantly improve and extend what’s possible for the benefit of patients with thrombosis. Patients are kept at the heart of everything that is done.
In 2018, LEO Pharma has successfully partnered and collaborated with both World Thrombosis Day and European Cancer Patient Coalition (ECPC) to increase the awareness and advance the knowledge of Cancer Associated Thrombosis (CAT) with both Healthcare Professionals and patients.
The company continues on the path they've chartered in thrombosis for more than 110 years, building, sharing and reinvesting in knowledge. The collective skills and efforts from everyone at LEO Pharma and its partners are the basis for their success.
Today, we are delighted to welcome LEO Pharma as our new sponsor, that supports us with an unrestricted educational grant. Welcome!
Would you like to read more about LEO Pharma’s activity in thrombosis? Click here.